SlideShare une entreprise Scribd logo
1  sur  51
The International Federation
          of Head and Neck Oncologic Societies
Current Concepts in Head and Neck Surgery and Oncology 2012




       Thyroid Cancer
    Treatment of the Neck

                 Ashok Shaha
2012   “New York, the nation’s thyroid gland”
                             – Christopher Morley (1890-1957), "Shore Leave"
“When a things ceases to
   be a subject of
   controversy, it ceases to
   be a subject of interest.”
                William Hazlitt
2012
American Thyroid Association (ATA)
    Consensus Review of the Anatomy,
Terminology and Rationale for Lateral Neck
Dissection in Differentiated Thyroid Cancers
                The ATA Surgical Affairs Committee
Lateral Neck Dissection for Well Differentiated Thyroid Cancer Sub-
                            Committee

                 •  Robert L. Ferris, MD, PhD
                 •  David Goldenberg, MD
                 •  Megan Haymart, MD
                 •  Ashok Shaha, MD
                 •  Sheila Sheth, MD
                 •  Julie Ann Sosa, MD
 2012            •  Brendan C. Stack, Jr., MD
                 •  Ralph P. Tufano, MD
Lymphatic Drainage of the Thyroid
             Gland
                   •  Bilateral drainage, extensive


                   •  High incidence of regional
                      metastasis – 40-70%

                   •  Multiple nodal groups at risk

                   •  Lymphatic channels parallel
                      venous drainage


                   •  Must be considered when
                      managing thyroid cancer
 2012
AJCC/UICC 2011 Staging
                 Nodal Staging for Thyroid Cancer


Nx – regional lymph nodes cannot be assessed
N0 – No regional lymph node metastasis
 N1 – Regional lymph node metastasis

       N1a                          N1b
       Metastasis to Level VI       Metastasis to
       pretracheal,                 unilateral, bilateral
       paratracheal,                or contralateral
       prelaryngeal,                cervical or superior
       delphian                     mediastinal
2012
                                    lymph nodes
2012
Diagrammatic Representation of the Neck Showing Various Nodal Levels and
                                Sublevels




  2012
Differentiated Carcinoma of the
           Thyroid Prognostic Factors

MSKCC                Mayo               Lahey         Karolinska

GAMES        AGES           MACIS       AMES          DAMES

Grade        Age            Metastases   Age          DNA
Age          Grade          Age                       Age
Metastases                  Completeness Metastases   Metastases
                            of resection

Extension    Extension      Invasion     Extension    Extension


Size         Size           Size         Size         Size
 2012
Pre-op Evaluation of the Neck
       •  CT scan

       •  Ultrasound: Suspected nodes
                 Location
                 FNA
                 Evaluation of contralateral neck



2012
2012
2012
2012
Thyroid Node-Met
       Detailed histologic characteristics
   Probably increases the risk of loco-regional
                   metastases
            Extra-thyroidal extension
                  (minor vs gross)
  Multifocality           Vascular invasion
  (microscopic vs         (intrathyroidal,
  macroscopic)            extrathyroidal)
2012
Thyroid- Node Met
       Clinco-pathologic features of the primary tumor
              Predict loco-regional metastases

                     Size of the primary tumor
                     > 0.5 cm in PTC
                     > 2 cm in FTC/HCC


Histology of the primary tumor              Age of the patient
PTC =TCV > FTC = HCC                        Children > Adults

                           Genotyping
2012                       BRAF positive
Ultrasonography for Detection of
           Regional Metastases
   •  May detect suspicious occult nodes

   •  Highly accurate when combined with FNAC

   •  Follow-up exams to detect increase in
       node size
   •  FNAC – Cytology
2012

                   Needle Wash - TgB
2012
2012
Differentiated Thyroid Cancer 1930-1985
            METASTASES RISK: Cumulative
       % at risk
       70        61%
       60                                         Nodal   Distant

       50
       40                                                       33 %
                                  30 %
       30                                  22 %       21%
       20                  10 %
       10
        0
               Papillary          Follicular          Hurthle
                810                 169                 59
2012
2012
2012
Number of LN’s Predicts Recurrence

                      (148 pts with LN mets, s/p total tx & routine VI, III, IV)

                 40
Recurrence (%)




                 30
                                                                       21%
                 20

                 10                                 7%
                               3%
                 0
                             0-5 LN+             6-10 LN+             > 10 LN+
             2012            (n=66)               (n=29)              (n=19)

                                                                        Leboulleux, JCEM, 2005
LN Extracapsular Extension & Recurrence

                           (148 pts with LN mets, s/p total tx & routine VI, III, IV)

                 40	
  
                                                                              32
Recurrence (%)




                 30	
  

                 20	
  

                 10	
  
                                                         4
                                     1
                   0	
  
                                    0                   0-3                  > 3
             2012                 (n=72)               (n=23)              (n=19)
                                   LN with Extracapsular Extension
                                                                             Leboulleux, JCEM, 2005
Factors:                   Loco-­‐Regional	
  Recurrence:
       Fewer	
  than	
  5	
  Metasta-c	
  LN’s                3%
                  pN1	
  but	
  cN0                           4%
               1-­‐3	
  LN’s	
  with	
  ENE                   4%
         All	
  Metasta-c	
  LN’s	
  <	
  2mm                 5%
             6-­‐10	
  metasta-c	
  LN’s                      7%
       Fewer	
  than	
  5	
  metasta-c	
  LN’s                8%
       More	
  than	
  5	
  metasta-c	
  LN’s                19%
       More	
  than	
  10	
  metasta-c	
  LN’s               21%
          Any	
  metasta-c	
  LN	
  >	
  1cm                 32%
        >3	
  metasta-c	
  LN’s	
  with	
  ENE               32%
          Any	
  metasta-c	
  LN	
  >	
  3cm                 73%

2012
Management Guidelines for Patients with Thyroid Nodules
         and Differentiated Thyroid Cancer

             The American Thyroid Association Guidelines Taskforce
                                  2009 Update



                                      R27b


         Prophylactic central-compartment neck dissection (ipsilateral or
          bilateral) may be performed in patients with papillary thyroid
         carcinoma with clinically uninvolved central neck lymph nodes,
               especially for advanced primary tumors (T3 or T4.)


  2012                         Recommendation C
Management of Neck in Thyroid Cancer
Clinically Negative Intraoperative Management

                Look for TE groove nodes

             Look for sup mediastinal nodes

                 Look for jugular nodes

            If any of these enlarged - do the
                   respective clearance

2012         Central compartment clearance
Management of Neck in Thyroid Cancer
Clinically Positive Intraoperative Management

•      “Berry picking” not recommended, higher
incidence of neck recurrence
 •     Modified neck dissection
 •     Preserving SCM
              •    IJV
              •    Accessory nerve
2012
              • Submandibular sal gland (Level I)
              •  RND - rarely indicated
Incision for Thyroidectomy
          and Neck Dissection




2012
Practical Tips for Neck Dissection in
           Thyroid Cancer
•      Review pre-op imaging very carefully –
       CT/MRI/Ultrasound
•      Review thyroid bed and paratracheal area
•      Pre-op status of vocal cords and calcium
       levels
•      Necklace incision
•      Identify accessory nerve
2012
Practical Tips for
       Neck Dissection in Thyroid Cancer
•      Look for jugulodigastric nodes

•      Avoid dissection on the surface of
       submandibular salivary gland

•      Look for supraclavicular and retrojugular node

•      Look for pre and paratracheal nodes

•      Avoid lymphatic injury – chyle leak, chyloma
2012
Delphian Node Metastases in Thyroid
              Cancer
       •    101 patients with Pap Ca

       •    25% had metastatic tumor to the Delphian node

       •    Relation of Delphian node positivity with    primary
            tumor and extra-thyroidal extension

       •    Association with additional node metastases to the
            central and lateral compartment

       •    Delphian node metastases is associated with heavier
            nodal burden
2012




                                                  Iyer/Shaha et al, Ann Surg 2011
Complications


       •  Paratracheal dissection - Hypoparathyroidism
                                    - Parathyroid
                                    autotransplantation
       •  Lymphatic/chyle leaks


       •  RLN injury


       •  Accessory nerve injury


2012   •  Horner’s Syndrome
Neck Dissection

       •  Modified neck dissection

       •  Selective neck dissection

       •  Compartment-oriented neck dissection

       •  Radical neck dissection

2012
Neck Dissection for Thyroid Cancer

        •    Role of pre-op ultrasound and U/S -guided FNA


        •    Microdissection (Tissel)


        •    Use of Gamma probe for intra-op localization


        •    Parathyroid autotransplantation
 2012
Sentinel Node Biopsy in Thyroid
                   Cancer

•      SLN can be located with
       radionucleide or

•      Blue dye

•      Limited or no clinical application


2012
Rising Thyroglobulin

       •    Generally recurrence in nodes
       •    U/S and FNA
       •    CT scan
       •    Neck dissection
       •    RAI
       •    Impact on recurrent long term
2012

            outcome
Good judgment comes
         from experience;
       and experience comes
        from bad judgment!
2012
Elective ND
                             Radical ND

     U/S & U/S FNA
   No clinical finding                         No prognostic
          Rising TGB                           implication



       Thyroglobulin
           follow-up
                                                Only therapeutic
                                                ND

            Clinical
            follow-up


2012
                         Central compartment
                                  ND
Extent of Metastatic Disease in Neck Nodes
     from Papillary Ca of the Thyroid
        Type                 Import on Outcome
   Micrometastasis                   None
   Mini metastasis                   None
    (by U/S of Tg)

   Minivolume metastasis             None
   Large volume metastasis           Maybe
                             (Regional or distant)

   Major metastasis                  Yes, older pt

                             (Regional or distant)
 2012
Selective Paratracheal Node
                 Dissection

       •    304 patients with Papillary Cancer

       •    No prophylactic node dissection
       •    Only therapeutic

       •    37% had therapeutic central compartment dissection

       •    Only 3 of 161 low risk patients developed central
            compartment recurrence (1.8%)


2012



                                                       Monchik et al., Surgery 2009
PET Scan & Neck Node Metastasis

       •    The nodal mets not responding to
            RAI and not localized by RAI


       •    PET positive


       •    Surgery – preferred approach
2012
Surgery for Recurrent Nodal
            Disease
       •  Frequent problem
       •  May be difficult to find the disease
       •  Missing neck nodes
       •  May be many other nodes
       •  Thyroglobulin may not become normal
       •  Other nodes may become obvious requiring further surgery
       •  Higher incidence of complications
       •  May not have much effect on long term outcome or
         prognosis
2012
Recurrent Neck Disease
            A Scientific Reality
                    OR
            Iatrogenic Problem

           Victim of Technology


A Balance Between Risk of the Disease &
2012
         Risk of the Treatment
•    Surgical experience is an important consideration while
            debating the issue of central compartment dissection

       •    Recurrence in the low-risk group necessitating central
            compartment reoperation is quite rare and in the high-risk
            group it is probably unavoidable

       •    It is important to develop a balance between the risk of
            recurrence against the benefit from elective nodal dissection

       •    Primum non nocere – FIRST DO NO HARM
2012



                                                             Surgery 2009; 146;1224-7
“The good physician
        treats the disease;
        the great physician
         treats the patient
       who has the disease.”


2012
        - Sir William Osler
Radiofrequency ablation of
  regional recurrence from well-
differentiated thyroid malignancy

               Dupuy DE, Monchik JM, et al

           Rhode Island Hospital, Providence, RI

            Surgery. 2001 Dec; 130(6):971-7.


2012
Percutaneous ethanol injection for
treatment of cervical lymph node
   metastases in patients with
   papillary thyroid carcinoma

                    Lewis BD, Hay ID, et al
         Dept. of Radiology, Mayo Clinic, Rochester, MN
        AJR Am J Roentgenol. 2002 Mar;178(3):699-704.




 2012
2012
2012
Summary
       •    High incidence of nodal mets in differentiated thyroid ca
                - But biologic difference

                - No survival impact

       •    Elective node dissection - not recommended

       •    Central compartment clearance - look for paratracheal and
            sup mediastinal and jugular nodes
       •    Lateral neck dissection - only if palpable nodes

       •    Modified neck dissection for clinical nodes

       •    Preserve SCM, IJV, XI and Level I

       •    No “berry picking”
2012
       •    Role of RAI
Summary
       Patients with multiple positive neck
       nodes from papillary ca may have
       additional paratracheal, sup
       mediastinal, or lateral neck nodes,
       and may remain with persistent mild
       hyperthyroglobulinemia. We may not
2012
       achieve biochemical cure.

Contenu connexe

Tendances

Thyroid malignancy
Thyroid malignancyThyroid malignancy
Thyroid malignancy
airwave12
 
thyroid surgery important
thyroid surgery importantthyroid surgery important
thyroid surgery important
talal mohamed
 

Tendances (20)

Types of neck dissection
Types of neck dissectionTypes of neck dissection
Types of neck dissection
 
Rectal cancer By Dr Efrem Ayalew Wossen
Rectal cancer By Dr Efrem Ayalew WossenRectal cancer By Dr Efrem Ayalew Wossen
Rectal cancer By Dr Efrem Ayalew Wossen
 
Benign diseases of thyroid
Benign diseases of thyroid Benign diseases of thyroid
Benign diseases of thyroid
 
Thyroid cancer
Thyroid cancerThyroid cancer
Thyroid cancer
 
Tobacco and cancer kiran
Tobacco and cancer  kiran Tobacco and cancer  kiran
Tobacco and cancer kiran
 
THYROIDECTOMY
THYROIDECTOMYTHYROIDECTOMY
THYROIDECTOMY
 
Simple goitre and thyroiditis
Simple goitre and thyroiditisSimple goitre and thyroiditis
Simple goitre and thyroiditis
 
Thyroid cancer by J. Shah
Thyroid  cancer by  J. ShahThyroid  cancer by  J. Shah
Thyroid cancer by J. Shah
 
Recent Update on Management of Ulcerative Colitis
Recent Update on Management of Ulcerative ColitisRecent Update on Management of Ulcerative Colitis
Recent Update on Management of Ulcerative Colitis
 
Thyroid neoplasms
Thyroid neoplasmsThyroid neoplasms
Thyroid neoplasms
 
ADESIYAKAN MANAGEMENT OF SIMPLE MULTINODULAR GOITRE2
ADESIYAKAN MANAGEMENT OF SIMPLE MULTINODULAR GOITRE2ADESIYAKAN MANAGEMENT OF SIMPLE MULTINODULAR GOITRE2
ADESIYAKAN MANAGEMENT OF SIMPLE MULTINODULAR GOITRE2
 
Thyroid malignancy
Thyroid malignancyThyroid malignancy
Thyroid malignancy
 
Thyroid
ThyroidThyroid
Thyroid
 
Thyroid ca
Thyroid caThyroid ca
Thyroid ca
 
Carcinoma Thyroid
Carcinoma ThyroidCarcinoma Thyroid
Carcinoma Thyroid
 
Management of thyroid cancer
Management of thyroid cancerManagement of thyroid cancer
Management of thyroid cancer
 
Ca rectum
Ca rectumCa rectum
Ca rectum
 
Gall bladder cancer management
Gall bladder cancer managementGall bladder cancer management
Gall bladder cancer management
 
thyroid surgery important
thyroid surgery importantthyroid surgery important
thyroid surgery important
 
Toilet mastectomy for advanced breast cancer.
Toilet mastectomy for advanced breast cancer.Toilet mastectomy for advanced breast cancer.
Toilet mastectomy for advanced breast cancer.
 

Similaire à Thyroid cancer treatment of the neck by A. Shaha

The Epidemic of Thyroid Nodules: Which Should Undergo Fine Needle Aspiration?
The Epidemic of Thyroid Nodules: Which Should Undergo Fine Needle Aspiration?The Epidemic of Thyroid Nodules: Which Should Undergo Fine Needle Aspiration?
The Epidemic of Thyroid Nodules: Which Should Undergo Fine Needle Aspiration?
u.surgery
 
02 suh srs hyderabad 2013 (cancer ci 2013) john h. suh
02 suh srs hyderabad 2013 (cancer ci 2013) john h. suh02 suh srs hyderabad 2013 (cancer ci 2013) john h. suh
02 suh srs hyderabad 2013 (cancer ci 2013) john h. suh
Dr. Vijay Anand P. Reddy
 
Larynx Preservation: the Nonsurgical Approach by Jan B. Vermorken
Larynx Preservation: the Nonsurgical Approach by Jan B. VermorkenLarynx Preservation: the Nonsurgical Approach by Jan B. Vermorken
Larynx Preservation: the Nonsurgical Approach by Jan B. Vermorken
Eurasian Federation of Oncology
 
2.4 dr aleksandar celebic masterclass - dubrovnik 2011.
2.4 dr aleksandar celebic   masterclass - dubrovnik 2011.2.4 dr aleksandar celebic   masterclass - dubrovnik 2011.
2.4 dr aleksandar celebic masterclass - dubrovnik 2011.
European School of Oncology
 
IGRT &amp; IMRT In Head Neck Cancer
IGRT &amp; IMRT In Head Neck CancerIGRT &amp; IMRT In Head Neck Cancer
IGRT &amp; IMRT In Head Neck Cancer
Sapna Nangia
 
&lt;마더리스크> biomarkers of methylation
&lt;마더리스크> biomarkers of methylation &lt;마더리스크> biomarkers of methylation
&lt;마더리스크> biomarkers of methylation
mothersafe
 

Similaire à Thyroid cancer treatment of the neck by A. Shaha (20)

Cutaneous melanomas by A. Shaha
Cutaneous melanomas by A. ShahaCutaneous melanomas by A. Shaha
Cutaneous melanomas by A. Shaha
 
Lauro.wcio2011 ny
Lauro.wcio2011 nyLauro.wcio2011 ny
Lauro.wcio2011 ny
 
The Epidemic of Thyroid Nodules: Which Should Undergo Fine Needle Aspiration?
The Epidemic of Thyroid Nodules: Which Should Undergo Fine Needle Aspiration?The Epidemic of Thyroid Nodules: Which Should Undergo Fine Needle Aspiration?
The Epidemic of Thyroid Nodules: Which Should Undergo Fine Needle Aspiration?
 
02 suh srs hyderabad 2013 (cancer ci 2013) john h. suh
02 suh srs hyderabad 2013 (cancer ci 2013) john h. suh02 suh srs hyderabad 2013 (cancer ci 2013) john h. suh
02 suh srs hyderabad 2013 (cancer ci 2013) john h. suh
 
Kshivets Hong Kong Sydney2020
Kshivets Hong Kong Sydney2020Kshivets Hong Kong Sydney2020
Kshivets Hong Kong Sydney2020
 
Lung Cancer: 10-Year Survival
Lung Cancer: 10-Year Survival           Lung Cancer: 10-Year Survival
Lung Cancer: 10-Year Survival
 
C hoeffel imaging of gastroenteropancreatic neuroendocrine tumors jfim hanoi ...
C hoeffel imaging of gastroenteropancreatic neuroendocrine tumors jfim hanoi ...C hoeffel imaging of gastroenteropancreatic neuroendocrine tumors jfim hanoi ...
C hoeffel imaging of gastroenteropancreatic neuroendocrine tumors jfim hanoi ...
 
Radiosurgery For Brain Metastases !
Radiosurgery For Brain Metastases !Radiosurgery For Brain Metastases !
Radiosurgery For Brain Metastases !
 
Lung cancer
Lung cancerLung cancer
Lung cancer
 
Current Modalities in the Treatment of Lung Cancer
Current Modalities in the Treatment of Lung CancerCurrent Modalities in the Treatment of Lung Cancer
Current Modalities in the Treatment of Lung Cancer
 
Larynx Preservation: the Nonsurgical Approach by Jan B. Vermorken
Larynx Preservation: the Nonsurgical Approach by Jan B. VermorkenLarynx Preservation: the Nonsurgical Approach by Jan B. Vermorken
Larynx Preservation: the Nonsurgical Approach by Jan B. Vermorken
 
MELANOMA.pptx
MELANOMA.pptxMELANOMA.pptx
MELANOMA.pptx
 
Salivary gland tumors
Salivary gland tumors Salivary gland tumors
Salivary gland tumors
 
BALKAN MCO 2011 - A. Celebic - Thyroid cancer
BALKAN MCO 2011 - A. Celebic - Thyroid cancer BALKAN MCO 2011 - A. Celebic - Thyroid cancer
BALKAN MCO 2011 - A. Celebic - Thyroid cancer
 
2.4 dr aleksandar celebic masterclass - dubrovnik 2011.
2.4 dr aleksandar celebic   masterclass - dubrovnik 2011.2.4 dr aleksandar celebic   masterclass - dubrovnik 2011.
2.4 dr aleksandar celebic masterclass - dubrovnik 2011.
 
cups neck by Dr. Musaib Mushtaq.ppt
cups neck by Dr. Musaib Mushtaq.pptcups neck by Dr. Musaib Mushtaq.ppt
cups neck by Dr. Musaib Mushtaq.ppt
 
Ueda2016 thyroid nodule in practice - khaled el hadidy
Ueda2016 thyroid nodule in practice - khaled el hadidyUeda2016 thyroid nodule in practice - khaled el hadidy
Ueda2016 thyroid nodule in practice - khaled el hadidy
 
IGRT &amp; IMRT In Head Neck Cancer
IGRT &amp; IMRT In Head Neck CancerIGRT &amp; IMRT In Head Neck Cancer
IGRT &amp; IMRT In Head Neck Cancer
 
LND in Ca bladder and role of neoadjuvant-1 (1).pptx
LND in Ca bladder and role of neoadjuvant-1 (1).pptxLND in Ca bladder and role of neoadjuvant-1 (1).pptx
LND in Ca bladder and role of neoadjuvant-1 (1).pptx
 
&lt;마더리스크> biomarkers of methylation
&lt;마더리스크> biomarkers of methylation &lt;마더리스크> biomarkers of methylation
&lt;마더리스크> biomarkers of methylation
 

Plus de Eurasian Federation of Oncology

IV EAFO LIVE SURGERY MASTERCLASS “HEAD & NECK CANCER”
IV EAFO LIVE SURGERY MASTERCLASS “HEAD & NECK CANCER”IV EAFO LIVE SURGERY MASTERCLASS “HEAD & NECK CANCER”
IV EAFO LIVE SURGERY MASTERCLASS “HEAD & NECK CANCER”
Eurasian Federation of Oncology
 

Plus de Eurasian Federation of Oncology (20)

II Eurasian Hematology Forum “Management of Hemato- Oncologic & Orphan Disord...
II Eurasian Hematology Forum “Management of Hemato- Oncologic & Orphan Disord...II Eurasian Hematology Forum “Management of Hemato- Oncologic & Orphan Disord...
II Eurasian Hematology Forum “Management of Hemato- Oncologic & Orphan Disord...
 
Results of breast-conserving surgery in cancer patient
Results of breast-conserving surgery in cancer patient Results of breast-conserving surgery in cancer patient
Results of breast-conserving surgery in cancer patient
 
NEOADJUVANT PHOTODYNAMIC THERAPY IN THE SURGICAL TREATMENT OF PATIENT...
NEOADJUVANT  PHOTODYNAMIC  THERAPY  IN  THE  SURGICAL  TREATMENT  OF  PATIENT...NEOADJUVANT  PHOTODYNAMIC  THERAPY  IN  THE  SURGICAL  TREATMENT  OF  PATIENT...
NEOADJUVANT PHOTODYNAMIC THERAPY IN THE SURGICAL TREATMENT OF PATIENT...
 
High-dose chemotherapy with autologous stem cells transplantation in the trea...
High-dose chemotherapy with autologous stem cells transplantation in the trea...High-dose chemotherapy with autologous stem cells transplantation in the trea...
High-dose chemotherapy with autologous stem cells transplantation in the trea...
 
PULMONARY THROMBOEMBOLISM IN CANCER PATIENTS AFTER SURGERY
PULMONARY THROMBOEMBOLISM IN CANCER PATIENTSAFTER SURGERYPULMONARY THROMBOEMBOLISM IN CANCER PATIENTSAFTER SURGERY
PULMONARY THROMBOEMBOLISM IN CANCER PATIENTS AFTER SURGERY
 
A CASE SERIES OF BEVACIZUMAB IN COMPLEX THERAPY IN PATIENTS WITH ADVANCED SER...
A CASE SERIES OF BEVACIZUMAB IN COMPLEX THERAPY IN PATIENTS WITH ADVANCED SER...A CASE SERIES OF BEVACIZUMAB IN COMPLEX THERAPY IN PATIENTS WITH ADVANCED SER...
A CASE SERIES OF BEVACIZUMAB IN COMPLEX THERAPY IN PATIENTS WITH ADVANCED SER...
 
EFFICIENCY TREATMENT OF CHRONIC PAIN SYNDROME IN CANCER PATIENTS IV CLINICAL ...
EFFICIENCY TREATMENT OF CHRONIC PAIN SYNDROME IN CANCER PATIENTS IV CLINICAL ...EFFICIENCY TREATMENT OF CHRONIC PAIN SYNDROME IN CANCER PATIENTS IV CLINICAL ...
EFFICIENCY TREATMENT OF CHRONIC PAIN SYNDROME IN CANCER PATIENTS IV CLINICAL ...
 
китель англ
китель   англкитель   англ
китель англ
 
IV EAFO LIVE SURGERY MASTERCLASS “HEAD & NECK CANCER”
IV EAFO LIVE SURGERY MASTERCLASS “HEAD & NECK CANCER”IV EAFO LIVE SURGERY MASTERCLASS “HEAD & NECK CANCER”
IV EAFO LIVE SURGERY MASTERCLASS “HEAD & NECK CANCER”
 
EURASIAN SEMINAR ON PREVENTION & EARLY DETECTION OF CANCER
EURASIAN SEMINAR ON PREVENTION & EARLY DETECTION OF CANCEREURASIAN SEMINAR ON PREVENTION & EARLY DETECTION OF CANCER
EURASIAN SEMINAR ON PREVENTION & EARLY DETECTION OF CANCER
 
II Eurasian Anti-Tobacco Forum I April 26, 2013
II Eurasian Anti-Tobacco Forum I April 26, 2013II Eurasian Anti-Tobacco Forum I April 26, 2013
II Eurasian Anti-Tobacco Forum I April 26, 2013
 
II Eurasian Oncology Conference for Young Investigators | 25 April 2013 | Mos...
II Eurasian Oncology Conference for Young Investigators | 25 April 2013 | Mos...II Eurasian Oncology Conference for Young Investigators | 25 April 2013 | Mos...
II Eurasian Oncology Conference for Young Investigators | 25 April 2013 | Mos...
 
Eurasian Hospice, Palliative & Supportive Care Forum | 27-28 April 2013 | Mo...
Eurasian Hospice, Palliative & Supportive Care Forum  | 27-28 April 2013 | Mo...Eurasian Hospice, Palliative & Supportive Care Forum  | 27-28 April 2013 | Mo...
Eurasian Hospice, Palliative & Supportive Care Forum | 27-28 April 2013 | Mo...
 
Berezikova O.A. - Life without pain (Hospice, Palliative Care & Pain Control ...
Berezikova O.A. - Life without pain (Hospice, Palliative Care & Pain Control ...Berezikova O.A. - Life without pain (Hospice, Palliative Care & Pain Control ...
Berezikova O.A. - Life without pain (Hospice, Palliative Care & Pain Control ...
 
Berezikova O.A. - Palliative care (Hospice, Palliative Care & Pain Control - ...
Berezikova O.A. - Palliative care (Hospice, Palliative Care & Pain Control - ...Berezikova O.A. - Palliative care (Hospice, Palliative Care & Pain Control - ...
Berezikova O.A. - Palliative care (Hospice, Palliative Care & Pain Control - ...
 
Usenko O.I. - Need for palliative care strategy (Hospice, Palliative Care & ...
Usenko O.I.  - Need for palliative care strategy (Hospice, Palliative Care & ...Usenko O.I.  - Need for palliative care strategy (Hospice, Palliative Care & ...
Usenko O.I. - Need for palliative care strategy (Hospice, Palliative Care & ...
 
Osetrova O.A. - Samara Hospice (Hospice, Palliative Care & Pain Control - WCD...
Osetrova O.A. - Samara Hospice (Hospice, Palliative Care & Pain Control - WCD...Osetrova O.A. - Samara Hospice (Hospice, Palliative Care & Pain Control - WCD...
Osetrova O.A. - Samara Hospice (Hospice, Palliative Care & Pain Control - WCD...
 
Novikov G.A. - Palliative care in RF (Hospice, Palliative Care & Pain Control...
Novikov G.A. - Palliative care in RF (Hospice, Palliative Care & Pain Control...Novikov G.A. - Palliative care in RF (Hospice, Palliative Care & Pain Control...
Novikov G.A. - Palliative care in RF (Hospice, Palliative Care & Pain Control...
 
Cleminson Bruce - CONTEMPORARY PRINCIPLES OF PAIN MANAGEMENT (Hospice, Pallia...
Cleminson Bruce - CONTEMPORARY PRINCIPLES OF PAIN MANAGEMENT (Hospice, Pallia...Cleminson Bruce - CONTEMPORARY PRINCIPLES OF PAIN MANAGEMENT (Hospice, Pallia...
Cleminson Bruce - CONTEMPORARY PRINCIPLES OF PAIN MANAGEMENT (Hospice, Pallia...
 
Byalic M.A. - Social work in palliative care (Hospice, Palliative Care & Pai...
Byalic M.A. - Social work in palliative care  (Hospice, Palliative Care & Pai...Byalic M.A. - Social work in palliative care  (Hospice, Palliative Care & Pai...
Byalic M.A. - Social work in palliative care (Hospice, Palliative Care & Pai...
 

Thyroid cancer treatment of the neck by A. Shaha

  • 1. The International Federation of Head and Neck Oncologic Societies Current Concepts in Head and Neck Surgery and Oncology 2012 Thyroid Cancer Treatment of the Neck Ashok Shaha
  • 2. 2012 “New York, the nation’s thyroid gland” – Christopher Morley (1890-1957), "Shore Leave"
  • 3. “When a things ceases to be a subject of controversy, it ceases to be a subject of interest.” William Hazlitt 2012
  • 4. American Thyroid Association (ATA) Consensus Review of the Anatomy, Terminology and Rationale for Lateral Neck Dissection in Differentiated Thyroid Cancers The ATA Surgical Affairs Committee Lateral Neck Dissection for Well Differentiated Thyroid Cancer Sub- Committee •  Robert L. Ferris, MD, PhD •  David Goldenberg, MD •  Megan Haymart, MD •  Ashok Shaha, MD •  Sheila Sheth, MD •  Julie Ann Sosa, MD 2012 •  Brendan C. Stack, Jr., MD •  Ralph P. Tufano, MD
  • 5. Lymphatic Drainage of the Thyroid Gland •  Bilateral drainage, extensive •  High incidence of regional metastasis – 40-70% •  Multiple nodal groups at risk •  Lymphatic channels parallel venous drainage •  Must be considered when managing thyroid cancer 2012
  • 6. AJCC/UICC 2011 Staging Nodal Staging for Thyroid Cancer Nx – regional lymph nodes cannot be assessed N0 – No regional lymph node metastasis N1 – Regional lymph node metastasis N1a N1b Metastasis to Level VI Metastasis to pretracheal, unilateral, bilateral paratracheal, or contralateral prelaryngeal, cervical or superior delphian mediastinal 2012 lymph nodes
  • 8. Diagrammatic Representation of the Neck Showing Various Nodal Levels and Sublevels 2012
  • 9. Differentiated Carcinoma of the Thyroid Prognostic Factors MSKCC Mayo Lahey Karolinska GAMES AGES MACIS AMES DAMES Grade Age Metastases Age DNA Age Grade Age Age Metastases Completeness Metastases Metastases of resection Extension Extension Invasion Extension Extension Size Size Size Size Size 2012
  • 10. Pre-op Evaluation of the Neck •  CT scan •  Ultrasound: Suspected nodes Location FNA Evaluation of contralateral neck 2012
  • 11. 2012
  • 12. 2012
  • 13. 2012
  • 14. Thyroid Node-Met Detailed histologic characteristics Probably increases the risk of loco-regional metastases Extra-thyroidal extension (minor vs gross) Multifocality Vascular invasion (microscopic vs (intrathyroidal, macroscopic) extrathyroidal) 2012
  • 15. Thyroid- Node Met Clinco-pathologic features of the primary tumor Predict loco-regional metastases Size of the primary tumor > 0.5 cm in PTC > 2 cm in FTC/HCC Histology of the primary tumor Age of the patient PTC =TCV > FTC = HCC Children > Adults Genotyping 2012 BRAF positive
  • 16. Ultrasonography for Detection of Regional Metastases •  May detect suspicious occult nodes •  Highly accurate when combined with FNAC •  Follow-up exams to detect increase in node size •  FNAC – Cytology 2012 Needle Wash - TgB
  • 17. 2012
  • 18. 2012
  • 19. Differentiated Thyroid Cancer 1930-1985 METASTASES RISK: Cumulative % at risk 70 61% 60 Nodal Distant 50 40 33 % 30 % 30 22 % 21% 20 10 % 10 0 Papillary Follicular Hurthle 810 169 59 2012
  • 20. 2012
  • 21. 2012
  • 22. Number of LN’s Predicts Recurrence (148 pts with LN mets, s/p total tx & routine VI, III, IV) 40 Recurrence (%) 30 21% 20 10 7% 3% 0 0-5 LN+ 6-10 LN+ > 10 LN+ 2012 (n=66) (n=29) (n=19) Leboulleux, JCEM, 2005
  • 23. LN Extracapsular Extension & Recurrence (148 pts with LN mets, s/p total tx & routine VI, III, IV) 40   32 Recurrence (%) 30   20   10   4 1 0   0 0-3 > 3 2012 (n=72) (n=23) (n=19) LN with Extracapsular Extension Leboulleux, JCEM, 2005
  • 24. Factors: Loco-­‐Regional  Recurrence: Fewer  than  5  Metasta-c  LN’s 3% pN1  but  cN0 4% 1-­‐3  LN’s  with  ENE 4% All  Metasta-c  LN’s  <  2mm 5% 6-­‐10  metasta-c  LN’s 7% Fewer  than  5  metasta-c  LN’s 8% More  than  5  metasta-c  LN’s 19% More  than  10  metasta-c  LN’s 21% Any  metasta-c  LN  >  1cm 32% >3  metasta-c  LN’s  with  ENE 32% Any  metasta-c  LN  >  3cm 73% 2012
  • 25. Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid Cancer The American Thyroid Association Guidelines Taskforce 2009 Update R27b Prophylactic central-compartment neck dissection (ipsilateral or bilateral) may be performed in patients with papillary thyroid carcinoma with clinically uninvolved central neck lymph nodes, especially for advanced primary tumors (T3 or T4.) 2012 Recommendation C
  • 26. Management of Neck in Thyroid Cancer Clinically Negative Intraoperative Management Look for TE groove nodes Look for sup mediastinal nodes Look for jugular nodes If any of these enlarged - do the respective clearance 2012 Central compartment clearance
  • 27. Management of Neck in Thyroid Cancer Clinically Positive Intraoperative Management •  “Berry picking” not recommended, higher incidence of neck recurrence •  Modified neck dissection •  Preserving SCM •  IJV •  Accessory nerve 2012 • Submandibular sal gland (Level I) •  RND - rarely indicated
  • 28. Incision for Thyroidectomy and Neck Dissection 2012
  • 29. Practical Tips for Neck Dissection in Thyroid Cancer •  Review pre-op imaging very carefully – CT/MRI/Ultrasound •  Review thyroid bed and paratracheal area •  Pre-op status of vocal cords and calcium levels •  Necklace incision •  Identify accessory nerve 2012
  • 30. Practical Tips for Neck Dissection in Thyroid Cancer •  Look for jugulodigastric nodes •  Avoid dissection on the surface of submandibular salivary gland •  Look for supraclavicular and retrojugular node •  Look for pre and paratracheal nodes •  Avoid lymphatic injury – chyle leak, chyloma 2012
  • 31. Delphian Node Metastases in Thyroid Cancer •  101 patients with Pap Ca •  25% had metastatic tumor to the Delphian node •  Relation of Delphian node positivity with primary tumor and extra-thyroidal extension •  Association with additional node metastases to the central and lateral compartment •  Delphian node metastases is associated with heavier nodal burden 2012 Iyer/Shaha et al, Ann Surg 2011
  • 32. Complications •  Paratracheal dissection - Hypoparathyroidism - Parathyroid autotransplantation •  Lymphatic/chyle leaks •  RLN injury •  Accessory nerve injury 2012 •  Horner’s Syndrome
  • 33. Neck Dissection •  Modified neck dissection •  Selective neck dissection •  Compartment-oriented neck dissection •  Radical neck dissection 2012
  • 34. Neck Dissection for Thyroid Cancer •  Role of pre-op ultrasound and U/S -guided FNA •  Microdissection (Tissel) •  Use of Gamma probe for intra-op localization •  Parathyroid autotransplantation 2012
  • 35. Sentinel Node Biopsy in Thyroid Cancer •  SLN can be located with radionucleide or •  Blue dye •  Limited or no clinical application 2012
  • 36. Rising Thyroglobulin •  Generally recurrence in nodes •  U/S and FNA •  CT scan •  Neck dissection •  RAI •  Impact on recurrent long term 2012 outcome
  • 37. Good judgment comes from experience; and experience comes from bad judgment! 2012
  • 38. Elective ND Radical ND U/S & U/S FNA No clinical finding No prognostic Rising TGB implication Thyroglobulin follow-up Only therapeutic ND Clinical follow-up 2012 Central compartment ND
  • 39. Extent of Metastatic Disease in Neck Nodes from Papillary Ca of the Thyroid Type Import on Outcome Micrometastasis None Mini metastasis None (by U/S of Tg) Minivolume metastasis None Large volume metastasis Maybe (Regional or distant) Major metastasis Yes, older pt (Regional or distant) 2012
  • 40. Selective Paratracheal Node Dissection •  304 patients with Papillary Cancer •  No prophylactic node dissection •  Only therapeutic •  37% had therapeutic central compartment dissection •  Only 3 of 161 low risk patients developed central compartment recurrence (1.8%) 2012 Monchik et al., Surgery 2009
  • 41. PET Scan & Neck Node Metastasis •  The nodal mets not responding to RAI and not localized by RAI •  PET positive •  Surgery – preferred approach 2012
  • 42. Surgery for Recurrent Nodal Disease •  Frequent problem •  May be difficult to find the disease •  Missing neck nodes •  May be many other nodes •  Thyroglobulin may not become normal •  Other nodes may become obvious requiring further surgery •  Higher incidence of complications •  May not have much effect on long term outcome or prognosis 2012
  • 43. Recurrent Neck Disease A Scientific Reality OR Iatrogenic Problem Victim of Technology A Balance Between Risk of the Disease & 2012 Risk of the Treatment
  • 44. •  Surgical experience is an important consideration while debating the issue of central compartment dissection •  Recurrence in the low-risk group necessitating central compartment reoperation is quite rare and in the high-risk group it is probably unavoidable •  It is important to develop a balance between the risk of recurrence against the benefit from elective nodal dissection •  Primum non nocere – FIRST DO NO HARM 2012 Surgery 2009; 146;1224-7
  • 45. “The good physician treats the disease; the great physician treats the patient who has the disease.” 2012 - Sir William Osler
  • 46. Radiofrequency ablation of regional recurrence from well- differentiated thyroid malignancy Dupuy DE, Monchik JM, et al Rhode Island Hospital, Providence, RI Surgery. 2001 Dec; 130(6):971-7. 2012
  • 47. Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma Lewis BD, Hay ID, et al Dept. of Radiology, Mayo Clinic, Rochester, MN AJR Am J Roentgenol. 2002 Mar;178(3):699-704. 2012
  • 48. 2012
  • 49. 2012
  • 50. Summary •  High incidence of nodal mets in differentiated thyroid ca - But biologic difference - No survival impact •  Elective node dissection - not recommended •  Central compartment clearance - look for paratracheal and sup mediastinal and jugular nodes •  Lateral neck dissection - only if palpable nodes •  Modified neck dissection for clinical nodes •  Preserve SCM, IJV, XI and Level I •  No “berry picking” 2012 •  Role of RAI
  • 51. Summary Patients with multiple positive neck nodes from papillary ca may have additional paratracheal, sup mediastinal, or lateral neck nodes, and may remain with persistent mild hyperthyroglobulinemia. We may not 2012 achieve biochemical cure.